Inquiry into allergies and anaphylaxis in Australia – Submissions Closing SOON

As you may know, in early September Mr Trent Zimmerman MP announced a parliamentary inquiry into allergic diseases. The parliamentary inquiry will be undertaken by the Standing Committee on Health, Aged Care and Sport and will provide the opportunity for a thorough investigation into the many challenges around allergic disease management in Australia.

People living with allergic disease have an opportunity to provide input.

Submissions from interested individuals and organisations are invited by Thursday 24 October 2019. The inquiry’s preferred method of receiving submissions is by electronic format lodged online using a My Parliament account. Register here: Online Submission

Allergy & Anaphylaxis Australia will be lodging a submission, and we strongly encourage you to voice your concerns/needs so that the inquiry unfolds the difficulties faced by individuals living with allergic disease and make recommendations which will improve care and therefore quality of life. Details on how to lodge a submission are available at the Committee’s website.

If you have a child with food or insect allergy, consider asking them to write a submission (or a section of your submission if they're only little) as well.

Now is the time to have your voice heard and tell the government about your experiences living with allergic disease in Australia.

Not sure what to put in your submission? Have a read over current submissions here.

Allergy & Anaphylaxis Australia, through the National Allergy Strategy would like to acknowledge both Mr Trent Zimmerman MP and Minister for Health, Mr Greg Hunt for hearing our pleas and the pleas of many. We thank them for their commitment to undertake the parliamentary inquiry and for their ongoing support of Australians living with allergic disease, including food, insect, and drug allergy, the risk of anaphylaxis due to any cause, atopic dermatitis/eczema, allergic rhinitis/hay fever and allergic asthma.

Acute Anaphylaxis CSS
Acute Anaphylaxis Clinical Care Standard - Learn more...
Atopic Dermatitis
allergy250K teens/young adults
Food allergy training

Our Supporters

Diamond


Viatris
Sanofi
Nestle
Allergy Concepts

Platinum


  • Bulla
  • NSW Food Authority
  • Novartis
  • Pfizer

Gold


  • dbv technologies
  • Mondelez
  • Nurticia
Silver

  • abbvie
  • Australian Camps Association
  • Bayer
  • Sanctuary Early Learning
  • Sweet William


© 2023 ALLERGY & ANAPHYLAXIS AUSTRALIA
ABN: 70 693 242 620

 



ALLERGY & ANAPHYLAXIS AUSTRALIA
is supported by funding from the
Australian Government,
Department of Health.


ALLERGY & ANAPHYLAXIS AUSTRALIA acknowledges and pays respect to the traditional custodians of the lands on which we work, live and play.

IN AN EMERGENCY

If you are having an allergic reaction follow advice on your ASCIA Action Plan.

If in doubt, give the Anapen® or EpiPen®.

Do not call us for emergency advice.

If you do not have an ASCIA Action Plan and/or an Anapen® or EpiPen® call triple zero (000) for an ambulance.